Referenslitteratur
för:
ADHD, dyslexi och dyspraxi |
|
| |
FÖRFATTARE
OCH TIDSKRIFT |
PUBLICERAD |
HÄMTA
PDF |
| |
|
|
|
| |
1. Baker SM.
A biochemical approach to the problem of dyslexia.
J Learn Disabil 1985; 18: 581-4.
|
1985
|
|
| |
2. Burgess JR. Attention deficit hyperactivity disorder; observational and interventional studies. NIH workshop on omega-3 essential fatty acids in psychiatric disorder; National Institutes of Health, Bethesda, USA, 1998; Sept 2-3.
|
1998
|
|
| |
3. Colquhoun
I, Bunday S. A lack of essential fatty acids as a possible cause
of hyperactivity in children.
Medical Hopothesis 1981; 7: 673-9.
|
1981
|
|
| |
4. Hibbeln JR. Seafood consumption, the DHA content of mothers milk and prevalence of post-partum depression; a cross-national ecological analysis.
J Affect Dis 2001.
|
2001
|
|
| |
5.
Mortensen EL, Michaelsen KF, Sanders SA, Reinisch
JM.
The association between duration of brestfeeding and adult intelligence.
JAMA 2002; 287: 2365-71.
|
2002
|
|
| |
6. Pawlosky RJ et al. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans.
Journ. of Lipid Research 2001;42,1257-65.
|
2001
|
|
| |
7. Peet M, Horrobin DF. A dose ranging study of the effects of ethyl eicosapentaeonate in patients with ongoing depression in spite of apparently adequate treatment with standard drugs.
Arch Gen Psychiatry 2002; 59: 913-9.
|
2002
|
|
| |
8. Portwood, M. Developmental dyspraxia: the significance of diet.
Special Magazine, March 2002.
|
2002
|
|
| |
9. Puri BK, Richardson AJ, Horrobin DF, Easton T, Saeed N, Oatridge A, Hajnal JV, Bydder GM. Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalization of blood fatty acids, reduced neonatal membrane phospholipid turnover, and structural brain changes.
Int J Clin Pract 2000; 54: 57-63.
|
2000
|
|
| |
10. Puri
BK, Richardson AJ. Brain phospholipid metabolism in dyslexia assessed
by magnetic resonance spectroscopy.
Phospholipid Spectrum Disorder
in Neurology and Psychiatry 2003. Marius Press.
|
2003 |
|
| |
11. Puri
BK. Eicosapentaenoic acid (EPA rich essential fatty acid supplementation
in chronic fatigue syndrome asociated with symtom remissionand
structural brain changes.
Int Clin Practice 2004.
|
2004 |
|
| |
12. Richardson AJ, Puri BK. A randomised, double blind placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties.
Prog Neuropsychopharm Biol Psychiat 2002; 26: 233-9.
|
2002
|
|
| |
13. Richardson AJ, Montgomery P. The Oxford-Durham Study: A Randomized, Controlled Trial of Dietary Supplementation with Fatty Acids in Children with Developmental Coordination Disorder.
Pediatrics 2005; 115: 1360-66.
|
2005
|
Hämta här |
| |
14. Schachter HM et al. How efficacious and safe is short-acting methylphenidate for the treatment of attention deficit disorder in children and adolescents.
CMAJ 2001; 165: 1476 - 1488.
|
2001
|
|
| |
15. Sinn N, Bryan J. The effect of supplementation with polyunsaturated fatty acids and micronutrients on ADHD-related problems with attention and behaviour.
Journal of Developmental and Behavioural Pediatrics. In press. 2006.
|
2006
|
|
| |
16. Stevens
LJ, Zentall SS, Deck JL, et al. Essential fatty acid metabolism in
boys with attention-deficit hyperactivity disorder.
Am J Clin Nutr 1995; 62: 761-8.
|
1995 |
|
| |
17. Voigt RG, Uorente AM, Berretta MC, Boutte C, Fraley JK, Jensen CL, Heird WC. Docosahexaenoic acid (DHA) supplementation does not improve the symptoms of attention-deficit hyperactivity disorder (ADHD).
Pediatr Res 1999; 45: 17A.
|
1999
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |